CA3015685A1 - Methods of purifying collagen 7 - Google Patents

Methods of purifying collagen 7 Download PDF

Info

Publication number
CA3015685A1
CA3015685A1 CA3015685A CA3015685A CA3015685A1 CA 3015685 A1 CA3015685 A1 CA 3015685A1 CA 3015685 A CA3015685 A CA 3015685A CA 3015685 A CA3015685 A CA 3015685A CA 3015685 A1 CA3015685 A1 CA 3015685A1
Authority
CA
Canada
Prior art keywords
recombinant human
human collagen
subjecting
retentate
collagen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3015685A
Other languages
English (en)
French (fr)
Inventor
Igor Quinones-Garcia
Benjamin SIMEONE
Raymond LILLIE
Ting Yang
David Nichols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phoenix Tissue Repair Inc
Original Assignee
Phoenix Tissue Repair Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoenix Tissue Repair Inc filed Critical Phoenix Tissue Repair Inc
Publication of CA3015685A1 publication Critical patent/CA3015685A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA3015685A 2016-03-16 2017-03-10 Methods of purifying collagen 7 Pending CA3015685A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662309030P 2016-03-16 2016-03-16
US62/309,030 2016-03-16
PCT/US2017/021815 WO2017160636A1 (en) 2016-03-16 2017-03-10 Methods of purifying collagen 7

Publications (1)

Publication Number Publication Date
CA3015685A1 true CA3015685A1 (en) 2017-09-21

Family

ID=59852081

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3015685A Pending CA3015685A1 (en) 2016-03-16 2017-03-10 Methods of purifying collagen 7

Country Status (7)

Country Link
US (1) US10669327B2 (https=)
EP (1) EP3429615A4 (https=)
JP (2) JP6985282B2 (https=)
CN (1) CN109069592B (https=)
CA (1) CA3015685A1 (https=)
MX (1) MX2018011162A (https=)
WO (1) WO2017160636A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108463470B (zh) * 2015-12-23 2021-10-22 菲尼克斯组织修复公司 胶原蛋白7的组合物及其使用方法
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
US10792618B2 (en) * 2018-06-19 2020-10-06 Sartorius Stedim Biotech Gmbh Particle separation and/or purification of a fluid
EP3953380A4 (en) 2019-04-12 2023-01-25 Geltor, Inc. RECOMBINATION ELASTIN AND ASSOCIATED PRODUCTION
EP4061446A4 (en) 2019-11-20 2023-11-29 NxStage Medical, Inc. METHODS, DEVICES AND SYSTEMS FOR PROVIDING PERITONEAL DIALYSIS LIQUID FROM A POWDERED CONCENTRATE
CN113121638B (zh) * 2020-01-15 2022-06-14 鲁南制药集团股份有限公司 一种纯化重组蛋白的方法
GB2610313B (en) 2020-01-24 2024-07-03 Geltor Inc Animal-free dietary collagen
US11504716B2 (en) * 2020-06-05 2022-11-22 Pall Corporation Multiwell device and method of use
EP4225353A1 (en) * 2020-10-08 2023-08-16 Jellatech, Inc. Produce, isolate and/or extract collagen and/or gelatin from animal cell lines and/or tissue explants
KR20240004264A (ko) * 2021-03-04 2024-01-11 젤라텍, 인크. 배양된 동물 세포로부터의 콜라겐을 사용한 재료의 제조 방법
CN114805548B (zh) * 2021-12-29 2023-11-14 江苏创健医疗科技股份有限公司 一种重组胶原蛋白冻干纤维及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO599897A0 (en) * 1997-04-03 1997-05-01 Vidal, Linus Clear collagen for facial implants
US7855280B2 (en) 2005-09-15 2010-12-21 Wyeth Llc Separation methods
US9040484B2 (en) * 2011-04-26 2015-05-26 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen
EP2753704A4 (en) * 2011-08-03 2015-07-08 Lotus Tissue Repair Inc COLLAGEN 7 AND ASSOCIATED METHODS
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US20140031295A1 (en) * 2012-07-19 2014-01-30 Lotus Tissue Repair, Inc. Recombinant C7 and Methods of Use
CN112126634A (zh) 2013-01-09 2020-12-25 夏尔人类遗传性治疗公司 含用于纯化芳基硫酸酯酶a的方法
KR20160055940A (ko) 2013-09-24 2016-05-18 엘라스타겐 피티와이 리미티드 단백질 추출 방법

Also Published As

Publication number Publication date
EP3429615A4 (en) 2019-11-06
CN109069592B (zh) 2023-03-07
JP2022016605A (ja) 2022-01-21
JP6985282B2 (ja) 2021-12-22
CN109069592A (zh) 2018-12-21
EP3429615A1 (en) 2019-01-23
US10669327B2 (en) 2020-06-02
JP7340583B2 (ja) 2023-09-07
WO2017160636A1 (en) 2017-09-21
US20190077845A1 (en) 2019-03-14
JP2019511498A (ja) 2019-04-25
MX2018011162A (es) 2018-11-22

Similar Documents

Publication Publication Date Title
JP7340583B2 (ja) ７型コラーゲンの精製方法
JP5755136B2 (ja) 高濃度モノクローナル抗体溶液中のウイルス除去方法
CA2192683C (en) Filtration
JP7617004B2 (ja) 原薬及び製剤プロセスの統合による生物製剤製造のための連続的な製造プロセス
US20120282654A1 (en) Antibody purification
CN104245730B (zh) 源自血浆的免疫球蛋白的级分i‑iv‑1沉淀
AU2011280907A1 (en) Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma
CN102245206A (zh) 获得无赋形剂抗体溶液的方法
CN105358571A (zh) 方法
JP2018538270A5 (https=)
CA2924042C (en) Method for the clarification of high density crude cell culture harvest
AU2021414086A1 (en) Systems and Methods for Process Scale Isolation of Immunoglobulin G
EP4073084A1 (en) Protein bioprocess
WO2014144764A2 (en) Method for producing factor h from a plasma precipitation fraction
WO2025173024A1 (en) Purification process and formulation of recombinant anti rhd monoclonal antibodies
WO2025085544A1 (en) Integrated process for isolation of plasma proteins
AU682274C (en) Filtration
HK40051082A (en) A continuous manufacturing process for biologics manufacturing by integration of drug substance and drug product processes
EA049616B1 (ru) Непрерывный способ изготовления биопрепаратов посредством интеграции процессов получения лекарственного вещества и лекарственного препарата

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220307

C11 Application revival requested

Free format text: ST27 STATUS EVENT CODE: N-6-6-C10-C11-C106 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REINSTATEMENT REQUEST RECEIVED

Effective date: 20240716

C11 Application revival requested

Free format text: ST27 STATUS EVENT CODE: N-6-6-C10-C11-C106 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REINSTATEMENT REQUEST RECEIVED

Effective date: 20241031

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20241101

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD

Year of fee payment: 8

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: N-6-6-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250904

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: N-6-6-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250904

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251222

C13 Application revived following an application revival request

Free format text: ST27 STATUS EVENT CODE: A-6-2-C10-C13-C102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REINSTATEMENT REQUIREMENTS DEEMED COMPLIANT FOR ALL ABANDONMENT REASONS

Effective date: 20260206

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260206

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20260206

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20260209

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20260209

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20260220

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 9TH ANNIV.) - STANDARD

Year of fee payment: 9

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260302

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260302